RetaMaps

StrIVe Wellness NJ(Mens Health-Testosterone Replacement Therapy, Peptide Therapy, IV Therapy, Medical Weight Loss)

StrIVe Wellness NJ(Mens Health-Testosterone Replacement Therapy, Peptide Therapy, IV Therapy, Medical Weight Loss) · 560 Springfield Avenue · Westfield, NJ 07090

5.0· 23 Google reviews

Listing updated October 2, 2026

Retatrutide outlook for this practice

No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.

Care described on the practice's website

  • Medically supervised weight loss

About this practice

StrIVe Wellness Clinic is a wellness practice listed in Westfield, New Jersey, whose website also references Scotch Plains. The site describes testosterone replacement therapy, IV therapy and weight-loss programs, with a mission built on personalized care, education and support, and says one of its clinicians is a nurse practitioner with more than 10 years of oncology experience. Phone consultations are offered, per the site, and the listing also includes aesthetics. On Google the clinic holds a 5.0-star rating across 23 reviews dating back to 2025, with 1 in the past year, and reviewers most often mention the team's knowledge and the staff.

Services & access

Advertises semaglutide todayNot listed
Advertises tirzepatide todayNot listed
Telehealth visitsNot listed
Cash pay accepted—
Accepts insurance — per practice websiteYes
Accepting new patients — per practice websiteYes

"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.

Review activity

★ 5.0
Google rating · 23 reviews
1
reviews in the past year (avg ★ 5.0)
1
reviews mention weight loss

Counts computed by RetaMaps from public Google reviews; most recent review 2025-10-07. Read the reviews themselves on the practice's Google listing.

What patients say

Rated ★5.0 across 23 Google reviews. Of the 20 reviews we analyzed, 20 (100%) are positive (4–5★) and 0 (0%) are negative (1–2★).

What patients like

  • Knowledgeable, professional providers9 reviews
  • Friendly, helpful staff8 reviews
  • Feeling listened to3 reviews
  • Clean, comfortable office3 reviews

Common complaints

No negative reviews among those we analyzed.

5★
19
4★
1
3★
0
2★
0
1★
0

Most recent Google reviews

Joycelyn B.★★★★★2025-10-07

StrIVe Wellness NJ is incredible! Dr. Mercy is AMAZING — so quick and gentle with our shots, my partner and I were in and out in no time. She made the whole experience super easy. Plus, the office is gorgeous and so welcoming. Highly recommend it!

Arie T.★★★★★2025-09-11

My IV therapy session was such a positive experience. Mercy was incredibly knowledgeable, kind, and made me feel completely at ease throughout the process. I truly appreciated how she explained everything clearly and shared thoughtful health tips that went beyond just the IV treatment. I left feeling refreshed, supported, and confident in her expertise. Highly recommend!

D S.★★★★★2025-06-22

Highly recommend Strive for recovering after a night out. The practitioner was incredibly knowledgeable, kind, and helpful. Thanks for helping me feel like a human again!

Nana A.★★★★★2025-06-08

I am back to feeling like myself again

daiane p.★★★★★2025-04-26

Great place. So relaxing and the nurse is awesome. I actually took a nap while my IV was going in.

Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.

Nearby providers in Westfield

Retatrutide status
Phase 3 complete · Not FDA-approvedUpdated October 2, 2026

Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.

Development
Phase 3 complete
FDA status
Submission planned — Q1 2027 (Lilly guidance)
Availability
Not commercially available
Access routes
Clinical trials, or Lilly's expanded access program (physician must apply)

Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)

Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs